Ratto, G B <br/><br/>
Neo-adjuvant chemo/immunotherapy in the treatment of stage III (N2) non-small cell lung cancer: a phase I/II pilot study.  [electronic resource] 

 -  International journal of immunopathology and pharmacology   
 - 1005-16 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0394-6320 
<br/><br/><label>Standard No.: </label>10.1177/039463201102400418  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carcinoma, Non-Small-Cell Lung--immunology<br/>Chemotherapy, Adjuvant<br/>Chi-Square Distribution<br/>Cisplatin--administration & dosage<br/>Deoxycytidine--administration & dosage<br/>Disease-Free Survival<br/>Feasibility Studies<br/>Female<br/>Humans<br/>Immunotherapy--adverse effects<br/>Interleukin-2--adverse effects<br/>Italy<br/>Kaplan-Meier Estimate<br/>Leukapheresis<br/>Leukocytes, Mononuclear--immunology<br/>Lung Neoplasms--immunology<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Neoplasm Staging<br/>Pilot Projects<br/>Pneumonectomy<br/>Proportional Hazards Models<br/>Recombinant Proteins--therapeutic use<br/>Survival Rate<br/>Time Factors<br/>Treatment Outcome<br/>Gemcitabine